GRS Talent’s Post

Change at the top doesn’t mean decline, it means progress... It's no secret, across PE-backed healthcare - especially in Ophthalmology and Optometry, there’s been a noticeable shift in leadership recently But instead of a sign of slowdown, this often signals the next phase of growth. We’re seeing funds reposition their portfolio companies: ✅ Strengthening leadership teams ✅ Driving integration and operational efficiency ✅ And gearing up for the next wave of expansion or sale I've been through enough waves now in this space to know it's not worrying - it’s exciting Because leadership transitions like these open the door for the right operators - the ones who know how to scale, build culture, and create lasting enterprise value From what I’m seeing, 2026 is shaping up to be a huge year of opportunity for both growing groups and proven executives in this space #PrivateEquity #Ophthalmology #Optometry #HealthcareLeadership #ExecutiveSearch #HealthcareGrowth